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Abstract
Background—We recently showed that the ubiquitous Enterococcus faecalis ebp (endocarditis
and biofilm-associated pilus) operon was important for biofilm and experimental endocarditis. Here
we assess its role in murine urinary tract infection using wild type E. faecalis OG1RF and its
nonpiliated ebpA allelic replacement mutant (TX5475).
Methods—OG1RF and TX5475 were administered transurethrally in a 1:1 ratio (competition assay)
or individually (monoinfection). Kidneys and bladders were cultured 48 h postinfection. These strains
were also tested in a peritonitis model.
Results—No differences were observed in the peritonitis model. In mixed urinary infection,
OG1RF significantly outnumbered TX5475 in kidneys (P=0.0033) and bladders (P=<0.0001). More
OG1RF CFU were also recovered from kidneys of monoinfected mice at the four inocula tested
(P=0.015 to 0.049) and ID50s of OG1RF for kidney and bladder (9.1 × 101 and 3.5 × 103 CFU,
respectively) were two-three log10 lower than with TX5475. Increased tropism for the kidney relative
to the bladder was observed by both OG1RF and TX5475.
Conclusion—The ebp locus, part of the core genome of E. faecalis, contributes to infection in an
ascending UTI model and is the first such enterococcal locus shown to be important in this site.
INTRODUCTION
Among the various infections reported with Enterococcus faecalis, urinary tract infections
(UTI) are the most common [1-3]. Little is known about the bacterial factors necessary for E.
faecalis to cause infections in general and even less has been reported related to the urinary
tract [2,4,5]. The presence of Esp, encoded by an acquired gene, was shown to increase
persistence of bacteria in the urinary bladders of mice, with no histological changes, when a
parent and its esp mutant were used in a ascending urinary tract infection model [5]; however,
there was no difference found in kidneys. Kau et al. [2], using a similar model, demonstrated
Corresponding author: Barbara E. Murray, M. D. Division of Infectious Diseases Center for the Study of Emerging and Re-emerging
Pathogens, University of Texas Medical School at Houston 6431 Fannin, 2.112 MSB, Houston TX 77030 Phone (713) 500-6745 Fax
(713) 500-5495 E-mail: bem.asst E-mail: @uth.tmc.edu.
Potential conflict of interest: None reported
NIH Public Access
Author Manuscript
J Infect Dis. Author manuscript; available in PMC 2009 May 11.
Published in final edited form as:
J Infect Dis. 2007 June 1; 195(11): 1671–1677. doi:10.1086/517524.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
that E. faecalis has a preference for the kidney relative to the bladder and concluded that this
model can be used to study the factors involved in the pathogenesis of urinary tract infections.
E. faecalis is also known to form biofilm on biomedical devices such as urinary catheters and
central venous catheters and several genes [6-9] have been shown to be important for biofilm
formation among E. faecalis strains, including fsr via its effect on gelatinase [7,10,11]. Biofilm
likely contributes to the high occurrence of enterococci in UTIs in the hospital setting, in part
because of the large number of catheterized patients, and in part because biofilm formation
may promote persistence of bacteria in the urinary tract. Therefore, it is important to understand
the relationship between genes involved in biofilm formation and the pathogenicity of E.
faecalis in the urinary tract.
We recently identified and characterized the ebp operon (endocarditis and biofilm associated
pili) which consists of, ebpA, ebpB, ebpC and an associated srtC (encoding sortase C) gene
which also has an independent promoter [12]. These surface pili are immunogenic and
pleomorphic in nature and their role in the establishment of biofilms and infective endocarditis
in a rat model was shown using the wild type (w.t.) E. faecalis strain OG1RF and its isogenic
nonpiliated ΔebpA (TX5475) mutant. Our hypothesis here is that E. faecalis Ebp-associated
pili may play a role similar to that of the fimbriae of Escherichia coli and Proteus mirabilis in
promoting colonization and adherence to uroepithelium. In this study, using w.t. E. faecalis
OG1RF, which expresses sortase C-dependent pleomorphic surface pili [12], and its
nonpiliated TX5475, we describe their ability to colonize kidneys and bladders in both
monoinfection and a mixed infection competition assay in a murine UTI model. We also tested
both strains in a mouse peritonitis model of sepsis.
MATERIALS AND METHODS
Bacterial strains and growth conditions
Bacteria used in the study include wild type OG1RF (resistant to rifampicin 100 μg/ml, fusidic
acid 25 μg/ml) (ATCC 47077), a well-known plasmid-free isolate used in many laboratories
[13]; OG1RF is a medium biofilm producer [7] and has been shown to be pathogenic in various
animal models [12,14-17]. A recently described nonpiliated, biofilm-deficient ebpA isogenic
deletion (polar) mutant of OG1RF, TX5475 with ebpA replaced with kanamycin resistance
gene was also used [12]. Brain Heart Infusion broth (BHIB) (Difco Laboratories) was used for
routine bacterial growth. Kanamycin (KAN) and heat inactivated horse serum were purchased
from Sigma. The concentration of antibiotics used in BHI agar (BHIA) plates for the growth
of nonpiliated TX5475 was KAN 2000 μg/ml.
UTI model for competition assay, monoinfections and ID50 determination
Female, 4- to 6-week-old, outbred ICR mice (Harlan Sprague Dawley) with a mean weight of
25 g were used in this study. Pre-approved protocol and guidelines of the Animal Welfare
Committee of the University of Texas Health Science Center at Houston were followed
throughout the course of the animal experiments. Mice were prescreened for UTI by culturing
the urine ∼12 h prior to inoculation. The urinary bladders of mice were emptied by gently
pressing the abdomen before infecting them. For preparation for administration to mice,
bacteria were grown in 10 ml of BHIB + 40% horse serum for 10 h at 37°C with gentle shaking.
Cells were pelleted for 10 minutes (10,000 rpm at 10°C), and resuspended in 10 ml of 0.9%
saline. Further dilutions were also prepared in saline, and plated to determine the actual
inoculum that had been administered. An inoculation method similar to a recently described
mouse UTI model [2] was used. A group of 16 mice was used in the competition assay while
groups of 5 mice per inoculum were used in each of two independent monoinfection
experiments with combination of the results. In brief, isoflurane anesthetized mice were
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infected via intraurethral catheterization (polyethylene catheter, ∼2.5 - 3 cm long; outer
diameter, 0.61 mm; Clay Adams) with 200 μl of the bacterial suspension consisting of an
approximately 1:1 ratio of w.t. E. faecalis OG1RF:nonpiliated TX5475, respectively, in a
competition assay; two independent experiments using 10 and 6 mice, respectively, were
performed and the results were combined. In two independent monoinfection experiments, w.t.
OG1RF was used in the inocula range of 101 - 106 while the nonpiliated TX5475 was tested
in the inocula range of 103 - 106 to generate data for comparison of CFU recovered from kidneys
and bladder of mice as well as for the calculation of 50% infective dose (ID50). Similar to the
method described by Kau et al. [2], we also used an inoculum volume of 200 μl in order to
facilitate direct delivery of the bacteria to both bladder and kidneys, simultaneously. The
urethral catheter was removed immediately after injecting the bacteria, and all the animals were
provided free access to food and water during the course of study. Daily observations were
made for any morbidity and mortality in animals. Mice were euthanized by CO2 inhalation at
48 h after transurethral challenge, the urinary bladder and kidney pair were excised, weighed,
homogenized in 1 ml and 5 ml of saline, respectively, and dilutions were plated onto BHIA
for recovery of bacteria in case of monoinfections and onto BHIA and BHIA+KAN 2000 μg/
ml in the case of mixed infection in order to determine the recovered CFUs (%) of w.t. OG1RF
versus nonpiliated TX5475. The detection limit of bacteria in this experiment was 10 CFU.
Mice with sterile cultures of kidney and urinary bladder homogenates were considered to have
no UTI infection. Identity of the recovered test bacteria from infected organs was confirmed
by plating them on Bile Esculin Azide agar (BEA) and BHIA + RIF100 plates for w.t. E.
faecalis OG1RF and on BHIA + Kan2000, BHIA + RIF100 and BEA plates for the nonpiliated
TX5475. Randomly picked nonpiliated TX5475 colonies were also tested by PCR, pulsed-
field gel electrophoresis (PFGE) [18] and/or by high stringency hybridization of PFGE gels to
reconfirm the identity of test bacteria.
Mouse peritonitis model
E. faecalis strains OG1RF and TX5475 were tested using our previously published method
[17]. Mice were injected intraperitoneally with appropriate dilutions of premixed bacteria/
sterile rat fecal extract (SRFE) and were observed for 5 days. Two fold dilutions of both test
bacteria in a range of ∼1 × 108 – 1 × 109 CFU were used as the inocula for LD50 determination
using six mice per group. The LD50 was determined by the method of Reed and Muench
[19].
Statistics, ID50s, and mean virulence index
The log10 CFU per gram of TX5475 and w.t. OG1RF in tissue of each animal (kidney or
bladder) from mixed infection were analyzed for significance by the paired t test. Differences
in the log10 CFU of TX5475 versus w.t. OG1RF in monoinfections were evaluated by the
unpaired t test. Fisher's exact test was used to compare the total infection of kidneys and
bladders (combining all inocula) in monoinfection with OG1RF versus TX5475. Prism version
4.00 for Windows (GraphPad Software) was used for statistical analysis. The fifty percent
infective dose (ID50s) values were calculated by a previously published method [19]. The mean
virulence index was calculated using the following equation (as previously described for other
organisms in mixed infections [12,15,20]):
where GM-CFU is the geometric mean expressed as CFU.
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RESULTS
Competition assay
In the competition experiment, approximately equal numbers (as judged by OD at 600nm) of
w.t. OG1RF and TX5475 mutant were administered transurethrally. The actual CFU of w.t.
E. faecalis OG1RF and the TX5475 mutant (combined from two experiments) in the inoculum
mix were 1.1 × 107 and 1.2 × 107, respectively; thus, the percent of w.t. E. faecalis OG1RF in
the inoculum was 49% (figure 1). W.t. OG1RF outcompeted the TX5475 mutant in all 16 mice
at 48 h post infection, increasing significantly from time zero (T = 0) in kidneys and urinary
bladder, with mean paired differences of 3.1- fold (P = 0.0033) and 179- fold (P = <0.0001),
respectively (figure 1). The mean virulence indices of nonpiliated TX5475 relative to w.t.
OG1RF in kidneys and bladders were 0.30 and 0.005, respectively.
Monoinfection of kidneys and bladders and ID50s
Because of the possibly that nonpiliated TX5475 colonies may have adhered to or been
entrapped by the surface pili of OG1RF and, therefore, may have been retained at the infection
site/s during the course of experiment, we also performed monoinfections with four equal
inocula of each organism. The total number of kidneys infected (38/40 with OG1RF versus
27/40 with TX5475) (P=0.0031) and total urinary bladders infected (30/40 with OG1RF versus
18/40 with TX5475) (P=0.0115), combining from all four monoinfection inoculum groups
indicated that TX5475 was significantly attenuated in its ability to infect both kidneys and
bladders versus its parent strain w.t. OG1RF (table 1). CFU counts recovered from animals
showed that when mice (n=10) were infected with 1-4 × 103, 1-4 × 104, 1-4 × 105, 1-4 × 106
CFU of w.t. OG1RF, the GM-CFU recovered from kidneys at 48 after transurethral challenge
were 2.1 × 104, 2.4 × 105, 1.7 × 106, 1.0 × 106, respectively (figure 2). In mice infected with
2-4 × 103, 2-4 × 104, 2-4 × 105, 2-4 × 106 CFU of TX5475, the GM-CFU recovered from
kidneys were 6.2 × 101, 3.6 × 103, 1.3 × 104, 8.9 × 103, respectively (figure 2), showing ≥two
log10 reduction in GM-CFUs of TX5475 versus GM-CFUs of w.t. OG1RF for the same
inoculum (figure 2). The mean CFU differences (log10) seen in all four inocula groups (103,
104, 105 and 106) between w.t OG1RF versus nonpiliated TX5475 were 2.5 ± 1.2 (P=0.0493),
1.8 ± 0.9 (P=0.0490), 2.1 ± 0.8 (P=0.0156) and 2.1 ± 0.9 (P=0.0333), respectively, (figure 2).
In bladders after monoinfection, although fewer bladders were infected by TX5475 (table 1),
the CFU differences were not significant with mean differences (log10) of 1.2 ± 1.2, 0.9 ± 1.3
and 0.9 ± 1.1 (in the 103, 105 and 106 inocula group, respectively) and 2.7 ± 1.4 (in the 104
inoculum group). The results in table 1 also indicate tropism for the kidney, since 20 – 30% of
the urinary bladders were found to be sterile in the same mice whose the corresponding kidneys
were infected (OG1RF) and 20 – 50% of the urinary bladders were found to be sterile in the
same mice whose kidneys were infected with the nonpiliated TX5475. The ID50s derived from
monoinfection experiments using w.t. OG1RF for kidney pairs and urinary bladders were
determined to be 9.1 × 101 and 3.5 × 103 CFU, respectively, while the ID50s using TX5475
for kidneys and bladder were determined to be 1.67 × 104 and 1.68 × 105 CFU, respectively,
showing that ≥two log10 more cells were required to infect 50% of the mice versus w.t. OG1RF.
ID50s also showed that approximately one log10 fewer CFU of either bacteria were needed to
infect 50% of the kidney pairs than to infect 50% of the urinary bladders.
Mouse peritonitis model
In an experiment using six mice per inoculum, both test bacteria caused mortality at a similar
rate (monitored at 3- 6 h intervals for 96 h) in mice (data not shown) and were not significantly
different by statistical analysis using log rank (Mantel-Cox) test, although there was a small
(1.9 fold) decrease in LD50 for TX5475.
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DISCUSSION
E. faecalis was recognized as an important organism associated with UTIs as long ago as the
early 1900s, but much needs to be learned about the pathogenesis of this organism in this site.
Among gram negative bacteria, E. coli is the leading cause of community-acquired UTIs [4,
21-25] and E. coli surface fimbriae or pili (type 1, P and related fimbriae, and F1C fimbriae)
are known to mediate initial adherence [5,26-28]. Recently, it has been shown that the flagella
of uropathogenic E. coli contribute to the persistence of the organism in bladder and kidney
[29]. Among gram positive bacteria, pili have been recognized in the past few years [30-37]
but their role in UTI has not yet been reported. Our recently published study [12] showed the
presence of pleomorphic endocarditis and biofilm-associated pili on E. faecalis OG1RF and
that a nonpiliated ebpA deletion mutant of OG1RF (TX5475) was significantly attenuated in
a rat model of infective endocarditis and formed significantly less biofilm in an in vitro assay.
Results of the current study using w.t. OG1RF versus TX5475 was an effort to determine if
the ebp-locus played a role in colonization of kidneys and urinary bladders in a murine UTI
model. The reduced recovery of TX5475 mutant versus w.t. OG1RF from kidneys (≥2 log10)
and bladders (≥1 log10), evident with all four inocula used in monoinfection, confirmed this
hypothesis. Although our results with the ebpA allelic replacement mutant TX5475 (that
produces none of the three Ebp proteins) [12] unambiguously demonstrated a role for the
ebp locus in urinary tract infection in this model, we acknowledge that we have not definitively
excluded the possibility of an independent contributory effect of its associated sortase C. It is
unlikely, however, that srtC played an independent role under the conditions tested, because
RT-PCR at these conditions showed elevated levels of the independent srtC transcript
(Nallapareddy et al., unpublished data). Furthermore, the complementation of TX5475 with
srtC did not restore biofilm formation [12]. Our ongoing studies with different sortase mutants
may be helpful in identifying any additional effects of sortase C. Both test bacteria used for
infection in the present study were grown in 40% serum + BHIB. Serum was chosen for the
growth of test bacteria in the present study as our recently published study [12] showed an
enhanced level of Ebp when w.t E. faecalis OG1RF was grown in 40% horse serum + BHIB
versus growth in BHIB alone. It has previously been shown that growth in serum increased
the adherence of tested strains to urinary tract epithelial cells and that clinical UTI isolates
adhered to urinary tract epithelial cells more efficiently than to the cultured cells by at least
1.5- to 3-fold, with the greatest increase being observed in UTI strain adherence to Girardi
heart cells (8-fold) [38,39]. Similarly, others have shown the differential expression of several
virulence-related genes in E. faecalis in response to biological cues in serum and urine [40]
and it would be of interest to test growth in urine as well.
An E. faecalis protein that has been described previously as influencing bladder colonization
is Esp which is reported to be displayed on the cell surface; the esp gene was found significantly
more often in strains of human UTI origin than in fecal isolates [5,41]. A disruption mutation
in esp reduced colonization of the urinary bladder in an ascending model of urinary tract
infection [5], although this study failed to demonstrate any difference in bacterial counts in
kidneys after infection with the esp mutant versus its parent strain, even in mice whose bladders
showed differences. Another study which also used the ascending model of mouse urinary tract
infections was unable to show a role for aggregation substance (AS) or enterococcal binding
substance (EBS), either in competition assay or in mono-infection [4]. Both the esp mutant
testing and AS/EBS studies [4,5] noted inconsistent urinary bladder colonization in mice whose
kidneys were infected, as was also observed in the present study with both w.t. OG1RF and
TX5475; this is consistent with a previously published study of Kau et al. [2] that E. faecalis
has greater tropism for the kidneys. The Kau et al. study [2] showed that when the inoculum
volume of E. faecalis was increased from 50 μl to 200 μl, in order to facilitate direct delivery
of the bacteria to both the bladder and the kidneys simultaneously, there was more consistent
colonization and recovery of bacteria from >90% of kidneys in mice infected with E.
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faecalis. In preparing for this study, we also found that when 50 μl inocula were used to infect
the mice, only one of six mice had infected kidneys with no infected bladders versus using 200
μl inocula volume which showed six of six mice with infected kidneys and three of six mice
with infected bladder (data not shown). Kau et al. [2] suggested that many or most episodes of
enterococcal cystitis may be due to seeding from an upper tract infection and that asymptomatic
bacteriuria with enterococci is often localized to the upper tract rather than the bladder; although
we are unaware of data from humans that indicate that upper tract infection with enterococci
is more common, this is certainly an interesting hypothesis.
Competition assays in which equal CFUs (in a mixed suspension) are inoculated to infect
animals have been successfully used in endocarditis models [15,16,42] to differentiate the
infective capabilities of w.t. organisms and their isogenic mutants. Kau et al. [2] showed the
growth advantage by a pyelonephritis clinical isolate over a laboratory strain of E. faecalis in
the kidneys, but not in the bladder, in a mouse UTI model and showed utility of this model to
study factors involved in the pathogenesis of urinary tract infections, as it has been with E.
coli [29]. In the competition assay of the present study, we found a significant differences
between recovered CFUs of w.t. OG1RF versus the TX5475 from kidneys (3.1 fold) and
bladders (179 fold). However, in all four inoculum groups of monoinfections, the differences
seen in recovered CFUs of w.t. OG1RF versus TX5475 from kidneys were much greater (up
to 1000 fold) versus the differences seen in recovered CFUs from kidneys in the competition
assay. We suspect that the smaller differences seen between kidney counts of w.t. OG1RF and
the TX5475 in the competition assay might be due to some of the nonpiliated TX5475 cells
adhering to the Ebp surface pili of w.t. OG1RF and remaining at the infected sites and this
hypothesis is partially supported by our earlier observation of frequent association of Ebp pili
with more than one cell in immunogold electron micrographs [12]. Our previous study also
found that anti-Ebp stained pili were seen in few w.t. OG1RF cells (<20% of TSBG- and <2%
of BHIB-grown cells, respectively) and one possibility is that a low % of piliated w.t. OG1RF
cells could be immunologically advantageous to the organism [12]. It is also possible that in
vivo conditions increase production of pili.
In the mouse peritonitis model, TX5475 did not show significant attenuation versus w.t.
OG1RF during the course of infection although the total mortality showed ∼two fold more
cells of TX5475 were needed to cause disease in 50% of the animals. The, atmost, very modest
attenuation by TX5475 in peritonitis model versus the high attenuation observed in the UTI
model when compared with w.t. OG1RF shows the importance of selecting an appropriate
animal model in order to assess the effect of adhesin related genes. The Ebp proteins previously
have been recognized as the members of the microbial surface component recognizing adhesive
matrix molecules (MSCRAMM) family [43] and a UTI murine model appears to provide
suitable in vivo conditions to allow ebp-associated pili of w.t. OG1RF to attach and colonize
the host renal tissue.
In conclusion, a nonpiliated TX5475 mutant of OG1RF showed marked attenuation versus w.t.
OG1RF in terms of ID50, virulence index, CFU in kidneys after monoinfection and total
numbers of kidneys and bladders colonized in an ascending mouse UTI model. There was
increased tropism of each strain for kidneys versus bladders, and results with bladders also
showed attenuation of TX5475 based on ID50s and the competition assays. The degree of
attenuation of the nonpiliated TX5475 is impressive and is consistent with our previous report
showing significant reduction in biofilm production and attenuation in an infective endocarditis
rat model [12]. Our previous finding that 100% of 408 strains tested contain ebp genes using
high stringency hybridization indicates that these genes are part of the core E. faecalis genome
and suggests that all strains could rely on these pili for colonization and/or infection of tissues.
Extrapolating from a report that pilicides target and interfere with pilus assembly function and
disrupt the infection process of uropathogenic E. coli [44], these apparently conserved
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enterococcal surface pili could be a potential target for new and yet to be discovered gram
positive specific pilicides as a way to treat or prevent enterococcal urinary tract infections in
human.
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Figure 1.
Mixed infection (competition assay) by w.t. E. faecalis OG1RF and nonpiliated TX5475 in
the kidneys and urinary bladder of mice (n=16). Data are expressed as log10CFU of w.t. E.
faecalis OG1RF or TX5475. The log10CFU/gm from both kidneys were combined and
averaged. Solid diamonds and triangles represent w.t. E. faecalis OG1RF and TX5475,
respectively, from kidney homogenates and empty diamonds and triangles represent w.t. E.
faecalis OG1RF and TX5475, respectively, from urinary bladder homogenates. Horizontal
bars represent geometric mean titer. Mean fold difference in CFU are given. Log10 CFU were
compared for statistical significance using a paired t test.
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Figure 2.
Monoinfection (106, 105, 104, and 103 inocula) using w.t. E. faecalis OG1RF or nonpiliated
TX5475 in the kidneys of mice (n=10). Data are expressed as log10CFU/gm of w.t. E.
faecalis OG1RF or TX5475 recovered from kidney homogenates 48 hrs after transurethral
challenge. The log10CFU from both kidneys were combined and averaged. Solid and empty
triangles represent w.t. E. faecalis OG1RF and TX5475, respectively. Horizontal bars represent
geometric mean titer. Mean difference in CFU is given as log10 ± standard deviation (SD) for
the respective inocula. TX5475 CFUs (recovered from kidneys) were significantly reduced
versus OG1RF with all four inocula using unpaired t test.
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Table 1
Tropism for the kidneys by E. faecalis strains OG1RF and its isogenic nonpiliated ΔebpA (TX5475) mutant in a murine
model of ascending urinary tract infection
Infected kidney pair and urinary bladder
Inocula used Kidneys Bladder
OG1RF TX5475 OG1RF TX5475
103 8/10 3/10 5/10 3/10
104 10/10 8/10 7/10 3/10
105 10/10 8/10 8/10 6/10
106 10/10 8/10 10/10 6/10
ID50 9.1 × 101 1.6 × 104 3.5 × 103 1.6 × 105
Total infected 38/40 27/40 30/40 18/40
P=0.0031a P=0.0115b
a
P values, determined by Fisher's exact test, are for total kidneys infected by OG1RF compared with TX5475;
b
P values are for total urinary bladders infected by OG1RF compared with TX5475
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